BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22609882)

  • 1. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
    Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
    Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.
    Pulewka K; Wolff D; Herzberg PY; Greinix H; Heussner P; Mumm FHA; von Harsdorf S; Rieger K; Hemmati P; Hochhaus A; Hilgendorf I
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1613-1619. PubMed ID: 28424902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
    Merkel EC; Mitchell SA; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.
    Lutz M; Kapp M; Einsele H; Grigoleit GU; Mielke S
    Clin Transplant; 2014 Dec; 28(12):1410-5. PubMed ID: 25287756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
    Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
    Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
    Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
    Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation.
    El-Jawahri AR; Vandusen HB; Traeger LN; Fishbein JN; Keenan T; Gallagher ER; Greer JA; Pirl WF; Jackson VA; Spitzer TR; Chen YB; Temel JS
    Cancer; 2016 Mar; 122(5):806-12. PubMed ID: 26650840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
    Lee Sk; Cook EF; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
    Wolff D; Herzberg PY; Herrmann A; Pavletic SZ; Heussner P; Mumm F; Höfer C; Hilgendorf I; Hemmati PG; Holler E; Greinix H; Mitchell SA
    Bone Marrow Transplant; 2021 Jan; 56(1):243-256. PubMed ID: 32737446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
    Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coping and Modifiable Psychosocial Factors are Associated with Mood and Quality of Life in Patients with Chronic Graft-versus-Host Disease.
    Jacobs JM; Fishman S; Sommer R; Sereno I; Fenech A; Jankowski AL; Traeger L; Greer JA; Vanderklish J; Hunnewell C; Saylor M; Chen YB; Spitzer T; DeFilipp Z; Temel JS; El-Jawahri A
    Biol Blood Marrow Transplant; 2019 Nov; 25(11):2234-2242. PubMed ID: 31260800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
    Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
    Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life in 244 recipients of allogeneic bone marrow transplantation.
    Chiodi S; Spinelli S; Ravera G; Petti AR; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Frassoni F; Bacigalupo A
    Br J Haematol; 2000 Sep; 110(3):614-9. PubMed ID: 10997973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation.
    Kramer M; Heussner P; Herzberg PY; Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Freund M; Wolff D
    Support Care Cancer; 2013 Apr; 21(4):1121-9. PubMed ID: 23111942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Recipient Health-Related Quality of Life and Donor-Recipient Relationship following Sibling Pediatric Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Pieczonka A; Barańska M; Wachowiak J
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):401-406. PubMed ID: 31622770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
    Mathanda RR; Hamilton BK; Rybicki L; Advani AS; Colver A; Dabney J; Ferraro C; Hanna R; Kalaycio M; Lawrence C; McLellan L; Sobecks R; Majhail NS; Rotz SJ
    Biol Blood Marrow Transplant; 2020 Aug; 26(8):1505-1510. PubMed ID: 32439476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation.
    Newcomb R; Johnson PC; Cronin K; Choe JJ; Holmbeck K; Nabily A; Lark P; Rabideau DJ; DeFilipp Z; Chen YB; El-Jawahri A
    Transplant Cell Ther; 2023 Jun; 29(6):387.e1-387.e7. PubMed ID: 36958693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
    Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
    Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.